Roche Launches Algorithm Suite for Chronic Liver Disease Management
The panel integrates biomarker testing and digital tools to support fibrosis risk assessment and liver cancer surveillance.
Read MorePosted by CLP Edit Staff | May 27, 2026 | Analytical Software Systems, Cancer, Diagnostic Technologies |
The panel integrates biomarker testing and digital tools to support fibrosis risk assessment and liver cancer surveillance.
Read MorePosted by CLP Edit Staff | May 27, 2026 | Cardiovascular, Company News, Diabetes & Metabolic Diseases |
The new kit uses Tasso+ collection technology and certified laboratory analysis to monitor 17 health markers, including blood sugar and lipid levels.
Read MorePosted by CLP Edit Staff | May 26, 2026 | Cancer, Company News, Digital Pathology |
The $750 million deal aims to integrate AI-powered technology and image management systems into pathology laboratory workflows.
Read MorePosted by CLP Edit Staff | May 22, 2026 | Company News, Digital Pathology, Prostate |
Tempus has launched the ArteraAI Prostate Test, a CLIA-certified, CAP-accredited AI tool for metastatic hormone-sensitive prostate cancer, offering personalized risk estimates and designed to support treatment decisions, according to the company.
Read MorePosted by CLP Edit Staff | May 22, 2026 | Cancer, Company News, Molecular Diagnostics |
The FDA has approved Guardant360 Liquid CDx, a blood-based test that integrates genomic and epigenomic profiling for advanced cancer, offering a broader genomic footprint and faster results.
Read More